Guanazodine

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C9H20N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7N05KQ38YI, chemically known as guanidine, ((octahydro-2-azocinyl)methyl)- (8ci,9ci) but generally known as guanazodine, which bears US NIH Compound Identifier 36054. European Medicines Agency schedules Guanazodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07981MIG. The term GUANAZODINE is an International Non-Proprietary Name. World Health Organization schedules guanazodine in its Anatomical Therapeutic Chemical (ATC) Classification. GUANAZODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanazodine under HS 29339990 and SITC 51577. As of Q4 2014, GUANAZODINE remains the US FDA Preferred Term for this commodity. Guanazodine bears US NLM identifiers UMLS ID C0061940 and NCI Concept Code C83741. SMILES: N1C(CCCCCC1)C/N=C(/N)N.